EI
GSK icon

Ethic Inc’s GSK GSK Stock Holding History

Ethic Inc’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.97M Buy
171,193
+4,662
+3% +$247K 0.11% 176
2026
Q1 		$9.19M Sell
166,531
-1,617
-1% -$87.6K 0.14% 145
2025
Q4 		$8.25M Sell
168,148
-5,945
-3% -$277K 0.13% 160
2025
Q3 		$7.51M Buy
174,093
+14,505
+9% +$567K 0.12% 162
2025
Q2 		$6.16M Buy
159,588
+18,499
+13% +$707K 0.11% 193
2025
Q1 		$5.34M Buy
141,089
+34,185
+32% +$1.25M 0.11% 204
2024
Q4 		$3.62M Buy
106,904
+8,586
+9% +$309K 0.07% 279
2024
Q3 		$4.21M Sell
98,318
-26,213
-21% -$1.07M 0.11% 222
2024
Q2 		$4.79M Buy
124,531
+26,213
+27% +$1.1M 0.11% 196
2024
Q1 		$4.21M Buy
98,318
+1,074
+1% +$44.3K 0.11% 222
2023
Q4 		$3.6M Buy
97,244
+18,100
+23% +$650K 0.11% 223
2023
Q3 		$2.87M Sell
79,144
-19,914
-20% -$707K 0.1% 246
2023
Q2 		$3.53M Sell
99,058
-328
-0.3% -$11.8K 0.13% 190
2023
Q1 		$3.54M Buy
99,386
+6,146
+7% +$215K 0.14% 185
2022
Q4 		$3.28M Buy
93,240
+9,327
+11% +$311K 0.18% 149
2022
Q3 		$2.47M Sell
83,913
-5,610
-6% -$213K 0.17% 152
2022
Q2 		$4.87M Buy
89,523
+9,403
+12% +$519K 0.34% 64
2022
Q1 		$4.36M Buy
80,120
+26,784
+50% +$1.45M 0.3% 78
2021
Q4 		$2.94M Buy
53,336
+15,802
+42% +$822K 0.23% 108
2021
Q3 		$1.79M Buy
37,534
+22,258
+146% +$1.12M 0.18% 141
2021
Q2 		$760K Buy
15,276
+9,249
+153% +$444K 0.09% 262
2021
Q1 		$269K Sell
6,027
-10,367
-63% -$471K 0.05% 408
2020
Q4 		$754K Buy
16,394
+2,800
+21% +$129K 0.2% 126
2020
Q3 		$640K Buy
13,594
+2,716
+25% +$136K 0.24% 105
2020
Q2 		$555K Buy
10,878
+3,146
+41% +$161K 0.32% 83
2020
Q1 		$366K Buy
7,732
+2,343
+43% +$125K 0.31% 111
2019
Q4 		$317K Buy
+5,389
New +$300K 0.23% 145

Other funds holding GSK

DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return

Ethic Inc's GSK Position: Q2 2026 in Review

Ethic Inc increased its GSK (GSK) stake by 2.8% in Q2 2026, buying an estimated $247K and bringing the position to 171,193 shares worth $8.97M. The position accounts for 0.11% of the portfolio, ranked #176.

Ethic Inc first reported a position in GSK in Q4 2019 and has held it in 27 quarters since. The position peaked at $9.19M in Q1 2026. 396 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Ethic Inc held 171,193 shares of GSK worth $8.97M as of Q2 2026.
  • Ethic Inc bought 4,662 GSK shares in Q2 2026, an estimated $247K.
  • GSK made up 0.11% of Ethic Inc's portfolio in Q2 2026, its #176 holding.
  • Ethic Inc first reported a position in GSK in Q4 2019 and has held it in 27 quarters since.
  • Ethic Inc's GSK position peaked at $9.19M in Q1 2026.
  • 396 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.